Sign In
Last checked at 
10 Sep 2021 14:42
Ap19
Ā
Ā
Ā
FORMĀ 8.3
Ā
IRISHĀ TAKEOVERĀ PANEL
Ā
DISCLOSUREĀ UNDERĀ RULEĀ 8.3Ā OFĀ THEĀ IRISHĀ TAKEOVERĀ PANEL ACT,Ā 1997,Ā TAKEOVERĀ RULES,Ā 2013
Ā
DEALINGSĀ BYĀ PERSONSĀ WITHĀ INTERESTSĀ INĀ RELEVANTĀ SECURITIESĀ REPRESENTINGĀ 1%Ā ORĀ MORE
Ā
1. KEYĀ INFORMATION
Ā
Name of person dealing (Note 1) | J.P. Morgan Securities LLC |
Company dealt in | Xeris Pharmaceuticals, Inc. |
Class of relevant security to which the dealings being disclosed relate (Note 2) | $0.001 common stock |
Date of dealing | 09 September 2021 |
Ā
2. INTERESTSĀ ANDĀ SHORTĀ POSITIONS
Ā
(a) InterestsĀ andĀ shortĀ positionsĀ (followingĀ dealing)Ā inĀ theĀ classĀ ofĀ relevantĀ securityĀ dealtĀ inĀ (NoteĀ 3)
Ā | Long | Short | ||||
Ā | Number | Ā | (%) | Number | Ā | (%) |
(1) Relevant securities | 1,572,010 2.36 | 12,840 0.02 | ||||
(2) Derivatives (other than options) | Ā | Ā | ||||
(3) Options and agreements to purchase/sell | Ā | Ā | ||||
Total | 1,572,010 2.36 | 12,840 0.02 | ||||
| Ā | Ā | Ā | Ā | Ā | Ā | Ā |
Ā
Ā
Ā
Ā
1. DEALINGSĀ (NoteĀ 4)
Ā
(a) PurchasesĀ andĀ sales
Ā
Ā Purchase/sale | Ā Number of relevant securities | Ā Price per unit (USD) Ā (Note 5) |
Ā Purchase(New Borrow) Ā Ā Purchases | Ā 29,500 Ā Ā 4 | Ā N/A Ā Ā 2.6300 USD |
Ā
Ā
Ā
(b) DerivativesĀ transactionsĀ (otherĀ thanĀ optionsĀ transactions)
Ā
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (USD) (Note 5) |
Ā | Ā | Ā | Ā |
Ā
Ā
Ā
(c) OptionsĀ transactionsĀ inĀ respectĀ ofĀ existingĀ relevantĀ securities
Ā
Ā
(i) Writing,Ā selling,Ā purchasingĀ orĀ varying
Ā
Ā
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
Ā | Ā | Ā | Ā | Ā | Ā | Ā |
Ā
Ā
(ii) Exercising
Ā
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
Ā | Ā | Ā |
Ā
Ā
(d) OtherĀ dealingsĀ (includingĀ transactionsĀ inĀ respectĀ ofĀ newĀ securities)Ā (NoteĀ 4)
Ā
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
Ā | Ā | Ā |
Ā
Ā
Ap21
Ā
2. OTHERĀ INFORMATION
Ā
Agreements,Ā arrangementsĀ orĀ understandingsĀ relatingĀ toĀ optionsĀ orĀ derivatives
Ā
Ā
Ā
Ā
FullĀ detailsĀ ofĀ anyĀ agreement,Ā arrangementĀ orĀ understandingĀ betweenĀ theĀ personĀ disclosingĀ andĀ anyĀ otherĀ
personĀ relatingĀ toĀ theĀ votingĀ rightsĀ ofĀ anyĀ relevantĀ securitiesĀ underĀ anyĀ optionĀ referredĀ toĀ onĀ thisĀ formĀ orĀ relatingĀ
toĀ theĀ votingĀ rightsĀ orĀ futureĀ acquisitionĀ orĀ disposalĀ ofĀ anyĀ relevantĀ securitiesĀ toĀ whichĀ anyĀ derivativeĀ referred
toĀ onĀ thisĀ formĀ isĀ referenced.Ā IfĀ none,Ā this shouldĀ beĀ stated.
Ā
None
Ā
Ā
Ā
Ā
Ā
Ā
Ā
Ā
IsĀ aĀ SupplementalĀ FormĀ 8Ā attached?Ā (NoteĀ 9) Ā NO
Ā
Date of disclosure | Ā 10 September 2021 |
Contact name | Alwyn Basch |
Telephone number | 0207 742 7407 |
If a connected EFM, name of offeree/offeror with which connected | N/A |
If a connected EFM, state nature of connection (Note 10) | N/A |
Ā
Follow the stocks
